Europe debating how to regulate emerging genome editing technology

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

EU policymakers are about to embark on a process which will go a long way to shaping the future of plant breeding in Europe – and whether EU farmers will be able to benefit from an emerging new technology.

After years of contemplation, the European Commission is expected to publish soon, possibly by the end of October, its opinion on how the relatively new technology, genome editing, should be classified and regulated.

This will kick-start a process which will eventually determine whether crops created by the technology, or at least strands of it, should be classified as genetically modified organisms (GMOs).

Genome editing involves inserting pieces of DNA, known as ‘molecular scissors’ into a host plant to cut and alter the genome of the host plant. In its simplest form, the technology deletes or alters existing genes without introducing new DNA.

Prof Huw Jones, of Rothamsted Research, Hertfordshire, said genome editing had the potential to revolutionise plant breeding in Europe, but only if policymakers treat it fairly.

He said: “If it is seen as a non-GMO, it will streamline the approval process and could change how plant breeding is done.

“If it is seen as a GMO…All the subsequent negativity surrounding GM would effectively prevent them being used in Europe.”

Penny Maplestone, chief executive of the British Society of Plant Breeders, said: “How the technology develops from here is completely dependent on what happens in the regulatory world.

The environmental lobby sees things differently. Various non-Governmental organisations have already joined forces to oppose the new technology and demand it is regulated as GM.

Read full, original post: GM or not GM? Why key decisions on new technology will shape EU plant breeding

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Children’s Health Defense Press Conference
As measles deaths among the unvaccinated hit a 35-year high, Kennedy-founded Children’s Health Defense bizarrely blames doctors for slow-walking a cure
eden green vertical farm facility
Why vertical farming is not the panacea for our food production crisis that its proponents claim
Contrasting Portraits and Family Story
Congressional investigation targets RFK Jr.: Documents show HHS chief lied multiple times during his confirmation hearings
Screenshot-2026-11-06-at-12.33.30-PM
Freaked out: Is it ethically okay to create animals with human tissue–including from the brain to help save lives?
Professional Portrait Earth Backdrop
Viewpoint: November 13 is the long-predicted global doomsday. How a respected scientist got population growth catastrophe predictions so spectacularly wrong—fueling decades of junk science
Screenshot-2026-11-13-at-11.57.01-AM
JAMA survey: Who’s most likely to embrace the RFK Jr.-fueled lie that vaccines cause autism? Men, adults 35–44, blacks and Republicans
Glossy Chocolate in Glass Petri Dish
Chocolate-making cocoa beans are increasingly in short supply. There may be a biotech fix
Colorful GLP-1 Pens with Clocks_tagger
Biohacker influencers are claiming GLP-1 weight loss drugs extend lifespan. One mice experiment suggests there may be some truth to the claim
Screenshot-2026-11-13-at-2.44.51-PM
Viewpoint: How will the Democratic sweep impact abortion rights 
Microscopic IVF Egg Injection
With technical barriers to human embryo editing falling, ethical concerns escalate
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.